Peri-Intubation Adverse Events in the Critically Ill Child After Hematopoietic Cell Transplant

Kyle B Lenz1, Akira Nishisaki1, Robert B Lindell1

  • 1Division of Critical Care, Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Insights

Mechanically ventilated children after hematopoietic cell transplant (HCT) did not show increased adverse events during tracheal intubation (TI). This study found no significant association between HCT status and peri-intubation hypoxemia or hemodynamic events.

Area of Science:

  • Pediatric Critical Care Medicine
  • Hematology/Oncology
  • Anesthesiology

Background:

  • Mechanically ventilated children post-hematopoietic cell transplant (HCT) face higher morbidity and mortality.
  • Tracheal intubation-associated adverse events (TIAEs) and peri-intubation hypoxemia are linked to worse outcomes.

Purpose of the Study:

  • To investigate if adverse peri-intubation events occur more frequently in HCT patients compared to non-HCT oncologic or other pediatric intensive care unit (PICU) patients.
  • To determine if these events contribute to increased mortality in HCT recipients.

Main Methods:

  • Retrospective cohort study of critically ill children undergoing tracheal intubation (TI) between 2014 and 2019.
  • Data merged from quality improvement databases and chart review, focusing on HCT-related factors.
  • Primary outcome: composite of hemodynamic TIAE (hypotension, hypertension, arrhythmia, cardiac arrest) and/or peri-intubation hypoxemia (SpO2 < 80%).

Main Results:

  • 1,931 TI encounters included: 92 (4.8%) post-HCT, 319 (16.5%) with malignancy history, 1,520 (78.7%) neither.
  • Post-HCT children were older and more likely to have respiratory failure as an indication for intubation.
  • No significant difference in composite adverse events: 16% in HCT vs. 10% in non-HCT malignancy vs. 15% in others (OR 1.32, 95% CI 0.72-2.41, p=0.37 after adjustment).

Conclusions:

  • This single-center study found no association between HCT status and increased risk of hemodynamic TIAE or peri-intubation hypoxemia during tracheal intubation.
  • The findings suggest that while post-HCT patients have unique challenges, intubation-related adverse events may not be a primary driver of their worse outcomes.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
44
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
41
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
367
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
432